Annual EBITDA
$690.00M$868.00M-55.71%
Summary
- Current Value
- As of today, TEVA annual EBITDA is $690.00M, down -55.71% on
- Historical Performance
- TEVA annual EBITDA is down -76.03% over the past 3 years, and down -46.05% over the past 5 years
- All-Time High Comparison
- TEVA annual EBITDA is currently -87.33% below its historical high of $5.45B set on
- 3-Year Low Comparison
- TEVA annual EBITDA is +174.59% above its 3-year low of -$925.00M reached on an earlier date
- Sector Comparison
- TEVA annual EBITDA is higher than 92.71% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $690.00M | -55.7% | -76.0% | -46.0% | -79.2% | |
| Quarterly EBITDA | $1.32B | +5.4% | +37.8% | +20.9% | -10.7% | |
| TTM EBITDA | $4.62B | -4.3% | +11.9% | +2.5% | -9.0% | |
| Price | $32.40 | +50.0% | +208.0% | +192.7% | -40.0% | |
| PE Ratio | 52.84 | – | – | – | +258.2% | |
| Annual Revenue | $16.59B | +4.7% | +4.7% | -1.7% | +19.6% | |
| Annual EPS | -$1.46 | -191.5% | -486.5% | -59.0% | -165.4% | |
| Annual EBIT | -$369.00M | -191.1% | -123.8% | +16.7% | -115.3% | |
| Annual Net Income | -$1.97B | -220.1% | -531.6% | -96.8% | -198.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.56B | -55.7% | |
| 5Y | $2.88B | -76.0% | |
| All | $5.45B | -87.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$925.00M | N/A | +174.6% |
| 5Y | -$1.95B | N/A | +135.4% |
| All | -$15.39B | +104.5% |
EBITDA History
FAQ
What is the current annual EBITDA of TEVA?
As of today, TEVA annual EBITDA is $690.00M
What is 1-year change in TEVA annual EBITDA?
TEVA annual EBITDA is down -55.71% year-over-year
What is 3-year change in TEVA annual EBITDA?
TEVA annual EBITDA is down -76.03% over the past 3 years
How far is TEVA annual EBITDA from its all-time high?
TEVA annual EBITDA is currently -87.33% below its historical high of $5.45B set on December 31, 2014
How does TEVA annual EBITDA rank versus sector peers?
TEVA annual EBITDA is higher than 92.71% of companies in Healthcare sector
When is TEVA next annual earnings release?
The next annual earnings release for TEVA is on
Quarterly EBITDA
$1.32B$114.53M+9.49%
Summary
- Current Value
- As of today, TEVA quarterly EBITDA is $1.32B, up +9.49% on
- Historical Performance
- TEVA quarterly EBITDA is up +5.44% year-over-year, and up +37.76% over the past 3 years
- All-Time High Comparison
- TEVA quarterly EBITDA is currently -21.10% below its historical high of $1.67B set on
- 3-Year Low Comparison
- TEVA quarterly EBITDA is +65.87% above its 3-year low of $796.47M reached on
- Sector Comparison
- TEVA quarterly EBITDA is higher than 97.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.32B | +9.5% | +5.4% | +37.8% | +20.9% | |
| Annual EBITDA | $690.00M | – | -55.7% | -76.0% | -46.0% | |
| TTM EBITDA | $4.62B | +1.5% | -4.3% | +11.9% | +2.5% | |
| Price | $32.40 | +61.4% | +50.0% | +208.0% | +192.7% | |
| PE Ratio | 52.84 | +61.4% | – | – | – | |
| Quarterly Revenue | $4.49B | +4.6% | +3.5% | +26.1% | +12.8% | |
| Quarterly EPS | $0.37 | +50.7% | +196.9% | +647.4% | +109.4% | |
| Quarterly EBIT | $1.08B | +13.6% | +8.7% | +69.3% | +51.7% | |
| Quarterly Net Income | $436.03M | +51.5% | +211.8% | +626.7% | +110.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.32B | at high | |
| 3Y | $1.58B | -16.2% | |
| 5Y | $1.58B | -16.2% | |
| All | $1.67B | -21.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $928.00M | +42.4% | |
| 3Y | $796.47M | +65.9% | |
| 5Y | $796.47M | +65.9% | |
| All | -$651.20M | +302.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TEVA?
As of today, TEVA quarterly EBITDA is $1.32B
What is TEVA quarterly EBITDA most recent change?
TEVA quarterly EBITDA was up +9.49% on September 30, 2025
What is 1-year change in TEVA quarterly EBITDA?
TEVA quarterly EBITDA is up +5.44% year-over-year
How far is TEVA quarterly EBITDA from its all-time high?
TEVA quarterly EBITDA is currently -21.10% below its historical high of $1.67B set on June 30, 2017
How does TEVA quarterly EBITDA rank versus sector peers?
TEVA quarterly EBITDA is higher than 97.47% of companies in Healthcare sector
When is TEVA next earnings release?
The next earnings release for TEVA is on
TTM EBITDA
$4.62B$68.15M+1.50%
Summary
- Current Value
- As of today, TEVA TTM EBITDA is $4.62B, up +1.50% on
- Historical Performance
- TEVA TTM EBITDA is down -4.33% year-over-year, and up +11.86% over the past 3 years
- All-Time High Comparison
- TEVA TTM EBITDA is currently -27.93% below its historical high of $6.41B set on
- 3-Year Low Comparison
- TEVA TTM EBITDA is +22.29% above its 3-year low of $3.78B reached on
- Sector Comparison
- TEVA TTM EBITDA is higher than 97.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.62B | +1.5% | -4.3% | +11.9% | +2.5% | |
| Annual EBITDA | $690.00M | – | -55.7% | -76.0% | -46.0% | |
| Quarterly EBITDA | $1.32B | +9.5% | +5.4% | +37.8% | +20.9% | |
| Price | $32.40 | +61.4% | +50.0% | +208.0% | +192.7% | |
| PE Ratio | 52.84 | +61.4% | – | – | – | |
| TTM Revenue | $16.88B | +0.9% | +0.4% | +11.9% | +1.8% | |
| TTM EPS | $0.61 | +519.4% | +172.1% | +152.6% | +116.7% | |
| TTM EBIT | $3.60B | +2.5% | -4.6% | +28.2% | +23.0% | |
| TTM Net Income | $666.71M | +518.5% | +154.8% | +151.2% | +115.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.62B | at high | |
| 3Y | $4.83B | -4.3% | |
| 5Y | $4.83B | -4.3% | |
| All | $6.41B | -27.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.42B | +4.6% | |
| 3Y | $3.78B | +22.3% | |
| 5Y | $3.78B | +22.3% | |
| All | -$552.30M | +936.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TEVA?
As of today, TEVA TTM EBITDA is $4.62B
What is TEVA TTM EBITDA most recent change?
TEVA TTM EBITDA was up +1.50% on September 30, 2025
What is 1-year change in TEVA TTM EBITDA?
TEVA TTM EBITDA is down -4.33% year-over-year
How far is TEVA TTM EBITDA from its all-time high?
TEVA TTM EBITDA is currently -27.93% below its historical high of $6.41B set on September 30, 2015
How does TEVA TTM EBITDA rank versus sector peers?
TEVA TTM EBITDA is higher than 97.38% of companies in Healthcare sector
When is TEVA next earnings release?
The next earnings release for TEVA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- TEVA Official Website www.tevapharm.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/818686/000119312525266895/0001193125-25-266895-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312525020826/0001193125-25-020826-index.htm
- TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
- TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva